SEPCX
Price
$9.28
Change
+$0.06 (+0.65%)
Updated
Jun 3 closing price
Net Assets
1.01M
TRNEX
Price
$38.48
Change
+$0.27 (+0.71%)
Updated
Jun 3 closing price
Net Assets
2.32B
Interact to see
Advertisement

SEPCX vs TRNEX

Header iconSEPCX vs TRNEX Comparison
Open Charts SEPCX vs TRNEXBanner chart's image
Saratoga Energy & Basic Materials C
Price$9.28
Change+$0.06 (+0.65%)
VolumeN/A
Net Assets1.01M
T. Rowe Price New Era I
Price$38.48
Change+$0.27 (+0.71%)
VolumeN/A
Net Assets2.32B
SEPCX vs TRNEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SEPCX vs. TRNEX commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEPCX is a Buy and TRNEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.32B vs. SEPCX (1.01M). TRNEX pays higher dividends than SEPCX: TRNEX (2.27) vs SEPCX (1.60). SEPCX was incepted earlier than TRNEX: SEPCX (22 years) vs TRNEX (9 years). SEPCX (4.85) is less costly to investors than TRNEX (0.57). SEPCX is a more actively managed with annual turnover of: 47.00 vs. TRNEX (24.30). SEPCX has a lower initial minimum investment than TRNEX: SEPCX (250) vs TRNEX (500000). TRNEX annual gain was more profitable for investors over the last year : -3.63 vs. SEPCX (-11.99). SEPCX (55.21) and TRNEX (53.70) have equivalent 5 years return.
SEPCXTRNEXSEPCX / TRNEX
Total Expense Ratio4.850.57851%
Annual Report Gross Expense Ratio4.850.57851%
Fund Existence22 years9 years-
Gain YTD-1.3902.964-47%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01M2.32B0%
Annual Yield % from dividends1.602.2771%
Returns for 1 year-11.99-3.63331%
Returns for 3 years-10.43-5.37194%
Returns for 5 years55.2153.70103%
Returns for 10 years-14.15N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QASGX25.250.39
+1.57%
Federated Hermes MDT Small Cap Growth A
JFNSX61.870.21
+0.34%
Janus Henderson Global Life Sciences S
JEMZX9.51N/A
N/A
JHancock Emerging Markets Equity C
EEMHX8.60N/A
N/A
MFS Emerging Markets Equity Research R6
TMCAX11.53N/A
N/A
RBC SMID Cap Growth A